ArticlePloS one2021

Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNFα therapy in inflammatory bowel disease.

Naomi Karmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.